SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Pastimes : Scamelot, a dedicated thread to Cyto in Orlando -- Ignore unavailable to you. Want to Upgrade?


To: Cytotekk who wrote (62)5/28/1999 9:52:00 PM
From: Jim Bishop  Read Replies (1) | Respond to of 349
 
Liking MDTV more all the time. Lawyers held the news today, or so I'm told, it may come out Monday, not a holiday here, be good to watch it Tuesday.

Sheesh, NPEC, MEADE gave it to me at .07 but I was all in elsewhere, he/she was dead on.

STRU - if there is good news next week, look out!



To: Cytotekk who wrote (62)5/28/1999 10:12:00 PM
From: Jim Bishop  Read Replies (1) | Respond to of 349
 
DMEC, from investor-list - analystgroup.com

DIAMOND ENTMNT (OTC BB: DMEC): The stock lost half penny to finish at
$0.195 with a daily average volume. Basically, the stock was traded on the sidelines. In the past four weeks, over 50 million shares have been traded. The ratio of buy to sell is about 5:1. Huge accumulation is going on here! According to one source, several market makers are calling around for the shares. They are running short of over 14 million shares.
Basically, they got in the trap, as they started to short at teens by
hoping the stock would be back down its previous base at $0.05. They
don't have any clues to the developments of the company. Now they want to continue to short at twenties by hoping the stock would be back down to teens. With a significant pushover, we believe the stock will explode to $1-$2. That was about what happened to GRPV if you remember. But we feel DMEC is a much better company in terms of its fundamentals. DMEC has ongoing revenues over $3 millions and has own product lines, develops new product lines and looks out for new product lines. Furthermore, its outstanding shares and floating shares are only half of the shares that GRPV (TXCI now) has. Only thing we can do is to hold, to buy more, and to spread the word. Everybody will be a winner by getting in now, as market makers want to make money as well and will follow the market eventually. One more note, two major market makers have been heavily accumulating the shares in the past several days. The stock is rated strong buy under $0.22. Our short-term target price is $1 to $2.